1. 肺腺癌组织lncRNA CCAT1、ZEB1表达与患者临床病理参数和预后的关系.
- Author
-
李 方, 李延波, 聂 佳, and 侯晓明
- Subjects
- *
GENE expression , *LINCRNA , *PROPORTIONAL hazards models , *TRANSCRIPTION factors , *ZINC-finger proteins - Abstract
Objective: To investigate the expression of long chain non-coding RNA (LncRNA) colon cancer related transcription factor 1 (CCAT1) and zinc finger binding protein 1 (ZEB1) in lung adenocarcinoma tissues and their relationship with clinicopathological parameters and prognosis of patients. Methods: 138 lung adenocarcinoma patients who were admitted to our hospital from February 2017 to February 2020 were selected. Surgically resected cancer tissues and cancer adjacent tissues (more than 2 cm from the edge of cancer tissues) were taken. The expression of lncRNA CCAT1 and ZEB1 mRNA in cancer tissues and cancer adjacent tissues were detected by real-time fluorescence quantitative polymerase chain reaction. The expression of ZEB1 protein in cancer tissues and cancer adjacent tissues was detected by immunohistochemistry. The correlation between lncRNA CCAT1 and ZEB1 mRNA expression in cancer tissues and clinicopathological parameters of lung adenocarcinoma patients were analyzed. The prognosis of lncRNA CCAT1 (high and low expression) and ZEB1 mRNA (high and low expression) in lung adenocarcinoma patients were analyzed by Kaplan-Meier method. The prognostic factors of lung adenocarcinoma patients were analyzed by multivariate Cox proportional hazard models. Results: The relative expression levels of lncRNA CCAT1 and ZEB1 mRNA in lung adenocarcinoma cancer tissues were higher than those in cancer adjacent tissues, respectively (P<0.05). The relative expression of lncRNA CCAT1 and ZEB1 mRNA in cancer tissues of lung adenocarcinoma patients was positively correlated (r=0.532, P<0.05). The relative expression levels of lncRNA CCAT1 and ZEB1 mRNA in lung adenocarcinoma patients with TNM stage IIIa and lymph node metastasis were higher than those in patients with stage I~II and no lymph node metastasis (P<0.05). The 3-year overall survival cases of lncRNA CCAT1 high expression group and low expression group were 39(60.00) and 65(92.86)respectively. The 3-year overall survival cases of ZEB1 mRNA high expression group and low expression group were 41(62.12) and 63(91.30) respectively. Compared with the lncRNA CCAT1 low expression group and ZEB1 mRNA low expression group. The lncRNA CCAT1 high expression group and ZEB1 mRNA high expression group had lower 3-year overall survival rates (P<0.05). high expression of lncRNA CCAT1, high expression of ZEB1 mRNA and lymph node metastasis were independent risk factors for poor prognosis in lung adenocarcinoma patients (P<0.05). Conclusion: The expression of lncRNA CCAT1 and ZEB1 mRNA in lung adenocarcinoma tissues is up-regulate, the up-regulation of both expression is related to lymph node metastasis, and can lead to poor prognosis, they are expected to become a potential marker for evaluating the prognosis of lung adenocarcinoma patients. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF